stella
beta
A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer — Stella
Home
/
Locally Advanced Pancreatic Cancer
/
A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer
View on ClinicalTrials.gov
Recruiting
Back to Locally Advanced Pancreatic Cancer trials
A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer
Trial locations
(5 sites)
Norway
Haukeland University Hospital, Bergen, Norway
Stavanger University Hospital, Stavanger, Norway
University Hospital of North Norway, Tromsø, Norway
St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
Oslo University Hospital, Oslo
Follow this trial
Get notified in plain English when this trial's status changes. No account required.
Follow